Archive: 3/08/2016

Spending on compounded drugs skyrocketing

(HealthDay)—Government spending on compounded drugs has skyrocketed, raising concerns of fraud and overbilling, according to a report published by Kaiser Health News.

Aug 03, 2016
popularity3 comments 0

Targeted therapies beneficial in KRAS-mutated NSCLC

(HealthDay)—Targeted therapies that do not contain erlotinib can be beneficial for patients with KRAS-mutated (KRAS mut+) advanced non-small-cell lung cancer (NSCLC), according to a study published online Aug. 1 in the ...

Aug 03, 2016
popularity3 comments 0